Sartorius AG

EANS-Voting Rights: Sartorius AG
Release according to article 26, section 1 WpHG (Securities Trading Act) with the aim of Europe-wide distribution

--------------------------------------------------------------------------------
  Notification of voting rights transmitted by euro adhoc. The issuer is
  responsible for the content of this announcement.
-------------------------------------------------------------------------------- 
Announcement according to Article 21, Section 1 of the WpHG (share) 
Pursuant to sec. 21 subsection 1 WpHG, Bio-Rad Laboratories, Inc., Hercules,
California, USA, has informed us on April 01, 2011 of the following: 
1.	Pursuant to sec. 21 subsection 1 WpHG, Bio-Rad Laboratories, Inc., has
informed, that its share of voting rights on April 01, 2011 has exceeded the
threshold of 30% and on that day totaled 30.01% of the voting rights (2,809,299
voting rights) in Sartorius AG. 
Of these voting rights, 30.01% (2,809,299 voting rights) are to be attributed
pursuant to sec. 22 subsection 1 sentence 1 no. 1 WpHG. 
Voting rights that are to be attributed are held via the following companies
which are controlled by Bio-Rad Laboratories, Inc., and whose holdings of voting
rights amount to 3% each or more in Sartorius AG:
- Bio-Rad Luxembourg S.à.r.l.
- Bio-Rad France Holding SAS
- Bio-Rad Laboratories GmbH 
2.	Pursuant to sec. 21 subsection 1 WpHG, Bio-Rad Laboratories, Inc., has
informed in the name and on behalf of Bio-Rad Luxembourg S.à.r.l., Luxembourg,
Luxembourg, that the share of voting rights of Bio-Rad Luxembourg S.à.r.l. on
April 01, 2011 has exceeded the threshold of 30% and on that day totaled 30.01%
of the voting rights (2,809,299 voting rights) in Sartorius AG. 
Of these voting rights, 30.01% (2,809,299 voting rights) are to be attributed
pursuant to sec. 22 subsection 1 sentence 1 no. 1 WpHG. 
Voting rights that are to be attributed are held via the following companies
which are controlled by Bio-Rad Luxembourg S.à.r.l., and whose holdings of
voting rights amount to 3% each or more in Sartorius AG:
- Bio-Rad France Holding SAS
- Bio-Rad Laboratories GmbH 
3.	Pursuant to sec. 21 subsection 1 WpHG, Bio-Rad Laboratories, Inc., has
informed in the name and on behalf of Bio-Rad France Holding SAS that the share
of voting rights of Bio-Rad France Holding SAS on April 01, 2011 has exceeded
the threshold of 30% and on that day totaled 30.01% of the voting rights
(2,809,299 voting rights) in Sartorius AG. 
Of these voting rights, 30.01% (2,809,299 voting rights) are to be attributed
pursuant to sec. 22 subsection 1 sentence 1 no. 1 WpHG. 
Voting rights that are to be attributed are held via the following companies
which are controlled by Bio-Rad France Holding SAS and whose holdings of voting
rights amount to 3% each or more in Sartorius AG:
- Bio-Rad Laboratories GmbH 
4.	Pursuant to sec. 21 subsection 1 WpHG, Bio-Rad Laboratories, Inc., has
informed in the name and on behalf of Bio-Rad Laboratories GmbH, that the share
of voting rights of Bio-Rad Laboratories GmbH on April 01, 2011 has exceeded the
threshold of 30% and on that day totaled 30.01% of the voting rights (2,809,299
voting rights) in Sartorius AG. 
Sartorius AG
The Executive Board 
end of announcement                               euro adhoc
-------------------------------------------------------------------------------- 

Further inquiry note:

Katrin Sebastian
Stellvertret. Leiterin Konzernrechtsabteilung
Tel.: 0049 (0) 551 308 3849
E-Mail: katrin.sebastian@sartorius.com

Branche: Biotechnology
ISIN: DE0007165607
WKN: 716560
Index: CDAX, Prime All Share, Technology All Share
Börsen: Frankfurt / regulated dealing/prime standard
Berlin / free trade
Hamburg / free trade
Stuttgart / free trade
Düsseldorf / free trade
Hannover / free trade
München / free trade

Original-Content von: Sartorius AG, übermittelt durch news aktuell

Weitere Meldungen: Sartorius AG

Das könnte Sie auch interessieren: